DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens
Published December 18, 2024 · Recall initiated: November 7, 2024
Summary
FDA records medical device Class II recall Z-0677-2025, published December 18, 2024 and initiated November 7, 2024. Recalling firm: Diasorin Inc.; Status: Ongoing; Reported quantity: 21905 units; Lot: UDI/DI 80567713190605F, Lot Numbers: 225084, 232094, 234114, 259144, 221214, 252244, 230094, 224124, 205144, 228174, 228224, 223274, 219104, 217134, 233154, 236174, 224244, 232294, 229224, 251234, 221294, 210204, 223244, 222314. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Customer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diasorin Inc.
- Distributor
- Worldwide
- Lot
- UDI/DI 80567713190605F, Lot Numbers: 225084, 232094, 234114, 259144, 221214, 252244, 230094, 224124, 205144, 228174, 228224, 223274, 219104, 217134, 233154, 236174, 224244, 232294, 229224, 251234, 221294, 210204, 223244, 222314
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPhilips Allura Xper Systems (R7.6-R8.1). Labeled as the following: 1. Allura Xper FD10, Model Number: 722010.December 18, 2024
- FDAHybrid Recon software on Hermes Medical Imaging Suite version 6.1 Hybrid Recon software versions affected areDecember 18, 2024
- FDACardinal Health SMS Elastic Cuff Thumbhook Level 3 Isolation Gown, Full-Back, Product Codes AT6588-2XL,December 18, 2024
- FDAGalaxy bronchoscope (Product GALB-001) used with Instructions for use, Part: 10000752, part of the NoahDecember 18, 2024
- FDADiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620January 31, 2024
- FDAParvovirus B19 IgG EIA kit Part No. V519IGUSSeptember 9, 2020
Questions about this recall
Was DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens recalled?
Yes. FDA published recall Z-0677-2025 on December 18, 2024. Reported hazard: Customer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail